Facial Yoga Toning Program - A Pilot Study

This study has been terminated.
(Investigator no longer at Cleveland Clinic)
Sponsor:
Information provided by:
The Cleveland Clinic
ClinicalTrials.gov Identifier:
NCT00952549
First received: August 4, 2009
Last updated: January 15, 2010
Last verified: January 2010
  Purpose

The primary objective of this study is to determine the efficacy of a facial yoga exercise program on appearance and to measure patient satisfaction with facial yoga practice.


Condition Intervention Phase
Facial Atrophy Related to Age
Procedure: Facial Yoga Toning Program
Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Facial Yoga Toning Program - A Pilot Study

Further study details as provided by The Cleveland Clinic:

Primary Outcome Measures:
  • Clinical evaluations will be performed at each follow-up visit: 2 weeks, 4 weeks, 6 weeks and 8 weeks. Level of improvement will be quantified using the Global Aesthetic Improvement Scale. [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Secondary measures at each visit will also include level of subject satisfaction with the program and subject's assessment of any improvement in their overall appearance (based on the scale above). [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]

Enrollment: 0
Study Start Date: August 2009
Study Completion Date: September 2009
Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: Facial Yoga Toning Program
    Patients will be instructed on 18 exercises which are intended to strengthen and tone the muscles of facial expression. DVD is provided.
Detailed Description:

This is a single center prospective longitudinal pilot study of 27 subjects. The study will include 20 study subjects and 7 controls. Participants in this study will be healthy subjects 18 years and older with mild to moderate facial atrophy without a history of surgical or non-surgical treatment to the area. The study subjects will perform facial yoga and apply sunscreen (Neutrogena Helioplex SPF 55) daily. The controls will apply sunscreen alone daily for 8 weeks.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • over age 18 years

Exclusion Criteria:

  • pregnancy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00952549

Sponsors and Collaborators
The Cleveland Clinic
Investigators
Principal Investigator: Rebecca Tung, MD The Cleveland Clinic
Principal Investigator: Wilma Bergfeld, MD The Cleveland Clinic
  More Information

No publications provided

Responsible Party: Tung, Rebecca, Cleveland Clinic
ClinicalTrials.gov Identifier: NCT00952549     History of Changes
Other Study ID Numbers: FYTP
Study First Received: August 4, 2009
Last Updated: January 15, 2010
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Facies
Atrophy
Disease Attributes
Pathologic Processes
Pathological Conditions, Anatomical

ClinicalTrials.gov processed this record on April 15, 2014